Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
10/11/2023 | ROSENBERG MATTHEW HAMILTON | 23 | $70 | -93.96% | 0.03% |
11/13/2023 | FRANKLIN RESOURCES INC | 0 | $0 | -100.00% | 0.00% |
11/13/2023 | WELLS FARGO & COMPANY/MN | 0 | $0 | -100.00% | 0.00% |
11/13/2023 | NORTHERN TRUST CORP | 0 | $0 | -100.00% | 0.00% |
11/14/2023 | STATE STREET CORP | 0 | $0 | -100.00% | 0.00% |
12/18/2023 | VANGUARD GROUP INC | 0 | $0 | -100.00% | 0.00% |
11/15/2023 | MORGAN STANLEY | 0 | $0 | -100.00% | 0.00% |
11/09/2023 | GROUP ONE TRADING, L.P. | 0 | $0 | -100.00% | 0.00% |
11/09/2023 | RHUMBLINE ADVISERS | 0 | $0 | -100.00% | 0.00% |
11/13/2023 | GEODE CAPITAL MANAGEMENT, LLC | 0 | $0 | -100.00% | 0.00% |
11/03/2023 | WEALTHTRUST AXIOM LLC | 0 | $0 | -100.00% | 0.00% |
11/14/2023 | TOWER RESEARCH CAPITAL LLC (TRC) | 0 | $0 | -100.00% | 0.00% |
11/15/2023 | VIRTU FINANCIAL LLC | 0 | $0 | -100.00% | 0.00% |
11/03/2023 | PRIVATE ADVISOR GROUP, LLC | 0 | $0 | -100.00% | 0.00% |
11/14/2023 | SUVRETTA CAPITAL MANAGEMENT, LLC | 0 | $0 | -100.00% | 0.00% |
11/09/2023 | UBS GROUP AG | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 2 institutional investors and hedge funds held shares of Benitec Biopharma Inc.. The most heavily invested institutionals were:
Empery Asset Management, LP: 796,837
Fieldpoint Private Securities, LLC: 3
A. 0.03% of Benitec Biopharma Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 796,840 shares in the last 24 months. This purchase volume represents approximately $7.04 M in transactions.